Flatiron Prospective Evidence Generation

Clinical studies are facing high failure rates due to increasing complexity and staffing challenges, with 75% of research sites citing staffing as a major issue. To address these issues, regulatory bodies recommend prospective evidence generation and pragmatic approaches. Flatiron Health, an oncology real-world data (RWD) leader, has introduced Prospective Evidence Generation to enhance study design and execution. This method integrates pragmatic designs into standard care, leverages technology for improved patient recruitment and data quality, and optimizes study protocols, improving success rates. Learn more about how this approach enables improved efficiency for modern clinical trials without sacrificing scientific rigor.